// App-Quantinova.ai

: Long-term Impact of Antihypertensive Treatment and Tacrolimus Dose in Renal Allograft Recipients 5 Years Post-Transplantation

Researchers

Presenter

  • D. Rush

Principal Investigators

  • S. Cockfield

  • S. Wilson

  • J. Schwartz

Medical Centers

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • University of Alberta Hospital, Edmonton, Alberta, Canada

  • Astellas Pharma Global Development, Inc., Northbrook, IL

  • Astellas Pharma, Inc., Northbrook, IL

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Other

Disease

  • Acute cellular rejection

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Basiliximab

  • Tacrolimus

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multicenteric

  • Prospective

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved